Results 161 to 170 of about 238,380 (247)

Noradrenergic inhibition of definitive POMC neurons through direct and indirect mechanisms. [PDF]

open access: yesJ Neuroendocrinol
Lavoie O   +6 more
europepmc   +1 more source

Quantitative Analysis of Locus Coeruleus Neurons and Thalamic Noradrenergic Axons in a Progressive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine Monkey Model of Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Parkinson's disease is mainly characterized by dopaminergic neurodegeneration in the substantia nigra pars compacta (SNc) and α‐synuclein accumulation. The locus coeruleus (LC) is also affected in Parkinson's disease and linked to some nonmotor symptoms, but the extent and timing of its degeneration remain unclear.
Megan Carrillo   +6 more
wiley   +1 more source

Commentary: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice

open access: yesFrontiers in Neuroscience, 2018
Matthew J. Betts   +8 more
doaj   +1 more source

Reply to: comments on "The effects of norepinephrine in shockable cardiac arrest, a scoping review". [PDF]

open access: yesScand J Trauma Resusc Emerg Med
Bouman SJM   +6 more
europepmc   +1 more source

NOREPINEPHRINE [PDF]

open access: yesAnesthesiology, 1958
openaire   +1 more source

Comparison of vasopressin-first weaning versus norepinephrine-first weaning in critically ill patients. [PDF]

open access: yesInt J Clin Pharmacol Ther
Alshreef M   +8 more
europepmc   +1 more source

Need for standardization in norepinephrine dosage in the management of septic shock. [PDF]

open access: yesRev Peru Med Exp Salud Publica
Cerna J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy